Trial intelligence / Profile preview

Atorvastatin in Early Diffuse Systemic Sclerosis

NCT02370784Phase 2Completed

Start
Feb 2015
Primary completion
Dec 2018
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of atorvastatin in systemic sclerosis (SSc). Started Feb 2015; status: completed.

02

Drugs

atorvastatin
03

Conditions

systemic sclerosis (SSc)

Beyond the preview

Go deeper on NCT02370784.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02370784.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call